Design of the Reducing Diagnostic Error to Improve Patient Safety (REDEfINE) in COPD and asthma study: A cluster randomized comparative effectiveness trial
- PMID: 36280032
- DOI: 10.1016/j.cct.2022.106971
Design of the Reducing Diagnostic Error to Improve Patient Safety (REDEfINE) in COPD and asthma study: A cluster randomized comparative effectiveness trial
Abstract
Although spirometry is a simple, portable test and recommended for the diagnosis of asthma and chronic obstructive pulmonary disease (COPD), it is not routinely used in the primary care setting. Minorities and underserved populations are less likely to have spirometry assessment, leading to both over and misdiagnosis of asthma and COPD. Because dyspnea is a common symptom across multiple diseases, use of spirometry as a diagnostic tool is important. Missed, delayed, or misdiagnosis of asthma and COPD, which are considered diagnostic errors (DE), can lead to poor quality of care, increased morbidity and mortality, and increased costs to patients and health systems. Barriers to the use of spirometry have been identified at clinician/clinic and health systems levels. The REDEFINE program is designed to overcome identified barriers to spirometry use in primary care by utilizing health promoters (HPs) who perform spirometry within primary care clinics and work collaboratively with clinicians to incorporate the results at the point of care without interrupting clinic workflow. The REDEFINE trial is a comparative effectiveness study comparing outcomes of the REDEFINE program with usual care (UC) in primary care patients determined to be at increased risk of DE for asthma and COPD. The primary outcome will be all-cause hospitalizations. The secondary outcomes will be the proportion of accurate diagnosis of COPD, asthma, or asthma-COPD overlap based on initial diagnosis and spirometry and all cause and respiratory-related acute outpatient care and emergency department visits. In this report, we describe the design and methods for the REDEFINE trial. Trial registration: NCT03137303https://clinicaltrials.gov/ct2/show/NCT03137303?term=REDEFINE&draw=2&rank=1.
Keywords: Asthma; Chronic bronchitis; Chronic obstructive pulmonary disease (COPD); Diagnostic error; Emphysema; Quality of care; Spirometry.
Published by Elsevier Inc.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests.
Similar articles
-
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.Respir Med. 2018 Sep;142:48-52. doi: 10.1016/j.rmed.2018.07.015. Epub 2018 Jul 24. Respir Med. 2018. PMID: 30170801
-
Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.J Asthma. 2006 Jan-Feb;43(1):75-80. doi: 10.1080/02770900500448738. J Asthma. 2006. PMID: 16448970
-
The objective evaluation of obstructive pulmonary diseases with spirometry.Int J Chron Obstruct Pulmon Dis. 2016 Aug 25;11:2009-15. doi: 10.2147/COPD.S113774. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27616884 Free PMC article.
-
Causes of misdiagnosis of chronic obstructive pulmonary disease: A systematic scoping review.Respir Med. 2017 Aug;129:63-84. doi: 10.1016/j.rmed.2017.05.015. Epub 2017 May 29. Respir Med. 2017. PMID: 28732838 Review.
-
Screening for Chronic Obstructive Pulmonary Disease: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr. Report No.: 14-05205-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Apr. Report No.: 14-05205-EF-1. PMID: 27170970 Free Books & Documents. Review.
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
